Fig. 4From: Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trialsForest plots of pooled PFS in patients with localized esophageal cancer. a 1-year PFS. b 2-year PFS. c 3-year PFS. d 5-year PFS. PFS, progression-free survival; CET, cetuximabBack to article page